These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10971246)

  • 21. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
    Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of on-pump coronary bypass using heparin-bonded circuits and reduced anti-coagulation compare favorably with off-pump approach.
    O'Gara PJ; Natarajan V; Lilly K; Husain A; Shapira OM; Shemin RJ
    Perfusion; 2002 Mar; 17(2):91-4. PubMed ID: 11958309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery--a clinical study.
    Borowiec J; Thelin S; Bagge L; van der Linden J; Thörnö E; Hansson HE
    Ups J Med Sci; 1992; 97(1):55-66. PubMed ID: 1523735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study.
    Aldea GS; Doursounian M; O'Gara P; Treanor P; Shapira OM; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1996 Aug; 62(2):410-7; discussion 417-8. PubMed ID: 8694599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-coated circuit in coronary surgery. A clinical study.
    Sáenz A; Larrañaga G; Alvarez L; Greco E; Marrero A; Lunar M; Elósegui C; Ubago JL; Gallo I
    Eur J Cardiothorac Surg; 1996; 10(1):48-53. PubMed ID: 8776185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting.
    Mirow N; Minami K; Kleikamp G; Tenderich G; Puhlmann T; Körfer R
    Thorac Cardiovasc Surg; 2001 Jun; 49(3):131-6. PubMed ID: 11432470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet protection in coronary artery surgery: benefits of heparin-coated circuits and high-dose aprotinin therapy.
    Wendel HP; Schulze HJ; Heller W; Hoffmeister HM
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):388-92. PubMed ID: 10468249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations.
    Schreurs HH; Wijers MJ; Gu YJ; van Oeveren W; van Domburg RT; de Boer JH; Bogers AJ
    Ann Thorac Surg; 1998 Jul; 66(1):166-71. PubMed ID: 9692458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
    Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved blood cellular biocompatibility with heparin coated circuits during cardiopulmonary bypass.
    Belboul A; Akbar O; Löfgren C; Jungbeck M; Storm C; Roberts A
    J Cardiovasc Surg (Torino); 2000 Jun; 41(3):357-62. PubMed ID: 10952323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin.
    Harig F; Feyrer R; Mahmoud FO; Blum U; von der Emde J
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):111-8. PubMed ID: 10363611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.
    Renda G; Di Pillo R; D'Alleva A; Sciartilli A; Zimarino M; De Candia E; Landolfi R; Di Giammarco G; Calafiore A; De Caterina R
    Haematologica; 2007 Mar; 92(3):366-73. PubMed ID: 17339186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Descending thoracic aortic aneurysm repair with the aid of partial cardiopulmonary bypass: heparin-coated circuits versus nonheparin-coated circuits.
    Morishita K; Kawaharada N; Fukada J; Hachiro Y; Kurimoto Y; Fujisawa Y; Saito T; Abe T
    Artif Organs; 2005 Apr; 29(4):300-5. PubMed ID: 15787624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.
    Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.
    Øvrum E; Tangen G; Tølløfsrud S; Skeie B; Ringdal MA; Istad R; Øystese R
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1145-9. PubMed ID: 20709334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain injury and neuropsychological outcome after coronary artery surgery are affected by complement activation.
    Baufreton C; Allain P; Chevailler A; Etcharry-Bouyx F; Corbeau JJ; Legall D; de Brux JL
    Ann Thorac Surg; 2005 May; 79(5):1597-605. PubMed ID: 15854939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.